SOM Biotech announces its participation in the BIO-Europe Spring 2021 partnering event on March 22nd – 25th, which will take place digitally due to the pandemic situation.
Organized by the EBD Group, a global partnering event organizer, the BIO-Europe Spring event attracts leading decision-makers not only from the traditional pharma and biotech sectors but also the world´s most innovative scientific institutions and leading investors in life sciences.
Raúl Insa, CEO of SOM Biotech highlights: “The BIO-Europe is a very relevant global life science partnering event, that enables us to meet with executives of the leading drug development and pharmaceutical industries. Partnering is for SOM Biotech a key strategic pillar and the event offers us a unique opportunity to meet with potential partners to discuss strategic collaborations and share our latest drug development updates. Additionally, the event is a fantastic platform to meet qualified investors, present our strategic growth plan and explore future business opportunities”.
Maria Zimina, Business Development Manager of SOM Biotech remarks: “We look forward to meeting with potential partners at BIO-Europe Spring 2021 and continuing building a strong network of pharmaceutical companies and research institutions to boost our development pipeline and strengthen operations with our AI-ligand-based drug discovery technology SOMAIPRO”.